Press Releases
Amgen and UCB Announce Positive Phase 2 Results of AMG 785/CDP7851
Amgen and UCB announced positive top-line results from their Phase 2 clinical study comparing sclerostin-antibody AMG 785/CDP7851 to placebo in postmenopausal women with low bone mineral density (BMD) for the treatment of postmenopausal osteoporosis (PMO). This...
Press Releases
FDA Approves Roche’s HPV Test for Identifying Women at Highest Risk for Cervical Cancer
Roche announced that the US Food and Drug Administration (FDA) has approved the cobas HPV (Human Papillomavirus) Test which identifies women at highest risk for developing cervical cancer. This test will help physicians make early, more accurate decisions...
Press Releases
BioSante Pharmaceuticals Announces Pancreatic and Prostate Cancer Vaccine License
BioSante Pharmaceuticals, Inc. announced it has licensed its Pancreas Cancer Vaccine and Prostate Cancer Vaccine to Aduro BioTech, a clinical-stage immunotherapy company, solely for use in combination with Aduro's proprietary vaccine platform based on Listeria monocytogenes (Lm). ...
Press Releases
Trophos presents data at the American Academy of Neurology on SMA and MS
Trophos SA, a clinical stage pharmaceutical company developing innovative therapeutics from discovery to clinical validation for indications with under-served needs in neurology and cardiology, announces today that Trophos has described the design of its pivotal clinical study of olesoxime...
Press Releases
CIT strengthens services in immunotoxicology
CIT, a leading European CRO specializing in non-clinical health and safety research, is pleased to announce the appointment of a new multi-disciplinary team of experienced scientists dedicated to providing non-clinical, advanced immunological research. The team, comprising of study directors,...
Press Releases
PharmaDiagnostics’ SoPRano (TM) wins prestigious product award at SBS 2011
PharmaDiagnostics NV, a company developing and marketing a broadly-enabling, label-free screening technology that uniquely does not require specialized equipment, announces today that their SoPRano(TM) technology has won its third award in 12 months. SoPRano was awarded an SLAS (Society...
Press Releases
Sun Pharma and Merck Establish Joint Venture to Develop and Commercialize Novel Formulations and Combinations of Medicines
Merck & Co., Inc., a global health care leader, known as MSD outside the United States and Canada,and Sun Pharmaceutical Industries Ltd., (“Sun Pharma”) a leading Indian multinational pharmaceutical company, today announced the creation of a joint venture...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
